RESUMO
Previously we have shown that our routine portal imaging (PI) of the craniofacial region in pediatric brain tumor patients contributed an additional 2%-3% of the prescribed dose and up to 200 cGy to the planning target volume (PTV) and nearby organs at risk (OARs). The purpose of this study is to quantify the reduction in dose to PTV and OARs from portal imaging (PI) of the craniofacial region of pediatric patients treated after the implementation of changes in our portal imaging practices. Twenty consecutive pediatric patients were retrospectively studied since the implementation of changes to our portal imaging procedure. Each received portal imaging of treatment fields and orthogonal setup fields to the craniofacial region. PI modifications included a reduction in the field size of setup orthogonal fields without loss of radiographic information needed for treatment verification. In addition, treatment fields were imaged using a single exposure, rather than double exposure. Dose-volume histograms were generated to quantify the dose to the target and critical structures through PI acquisition. These results were compared with our previous cohort of 20 patients who were treated using the former portal imaging practices. The mean additional target dose from portal imaging following the new guidelines was 1.5% of the prescribed dose compared to 2.5% prior to the new portal image practices (p < 0.001). With the new portal imaging practices, the percentage decrease in portal imaging dose to the brainstem, optic structures, cochlea, hypothalamus, temporal lobes, thyroid, and eyes were 25%, 35%, 35%, 51%, 45%, 80%, and 55%, respectively. Reductions in portal imaging doses were significant in all OARs with exception of the brainstem, which showed a trend towards significance. Changes to portal imaging practices can reduce the radiation dose contribution from portal imaging to surrounding OARs by up to 80%. This may have implications on both late toxicity and second cancer development in pediatric brain tumors.
Assuntos
Neoplasias Encefálicas/diagnóstico por imagem , Órgãos em Risco/efeitos da radiação , Planejamento da Radioterapia Assistida por Computador , Radioterapia Conformacional , Ecrans Intensificadores para Raios X/efeitos adversos , Adolescente , Adulto , Neoplasias Encefálicas/radioterapia , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Radiografia , Radiometria , Dosagem Radioterapêutica , Adulto JovemRESUMO
PURPOSE: Endourology is established in urology practice with routine use of fluoroscopic guidance. Medical personnel are rarely exposed to direct radiation exposure but secondary exposure occurs via radiation scatter. There are few reports on scatter radiation exposure and the subsequent risk to medical personnel involved in urological fluoroscopic procedures. We review the risks of scatter radiation exposure to medical personnel with reference to the routine use of fluoroscopic imaging in urological practice. MATERIALS AND METHODS: We measured staff radiation exposure during a series of ureteral endourological procedures using LiF:Mg,Ti thermoluminescent dosimeters placed at the extremities of the operating surgeon, the assistant and the scrub nurse. Doses for percutaneous nephrolithotomy (PCNL) procedures were calculated by extrapolating from the ureteral procedure thermoluminescent dosimeter data. Theoretical scattered radiation dose rates were also calculated. RESULTS: The average ureteral procedure fluoroscopy time was 78 seconds with an exposure rate of 71 kV, 2.4 mA. The surgeon received the highest radiation exposure with the lower leg (11.6 +/- 2.7 microGy) and foot (6.4 +/- 1.8 microGy) receiving more radiation than the eyes (1.9 +/- 0.5 microGy) and hands (2.7 +/- 0.7 microGy). For a predicted annual caseload of 50 ureteral cases, the dose received does not exceed 0.12% of the Ionising Radiations Regulations 1999 annual dose limit for adult workers. Radiation exposure during PCNLs is higher but does not exceed 2% of the annual dose limits even if 50 PCNLs are performed annually. CONCLUSIONS: Fluoroscopic screening results in radiation exposure of medical personnel. The estimate of maximum scatter radiation exposure to the surgeon for 50 PCNL procedures a year did not exceed 10 mGy. This amount is less than 2% of permissible annual limits of equivalent dose to the extremities. Medical personnel should be aware of scatter radiation risks and minimize radiation exposure when involved in fluoroscopic screening procedures.
Assuntos
Fluoroscopia/efeitos adversos , Doenças Profissionais/etiologia , Exposição Ocupacional/efeitos adversos , Lesões por Radiação/etiologia , Espalhamento de Radiação , Dosimetria Termoluminescente , Urologia , Humanos , Nefrostomia Percutânea , Doenças Profissionais/prevenção & controle , Doses de Radiação , Lesões por Radiação/prevenção & controle , Estudos Retrospectivos , Risco , Níveis Máximos Permitidos , Ureter/diagnóstico por imagem , Ureter/cirurgia , Ureteroscopia , Ecrans Intensificadores para Raios X/efeitos adversosRESUMO
The objectives of the present study were to (a) estimate the conceptus radiation dose and risks for pregnant women undergoing posteroanterior and anteroposterior (AP) chest radiographs, (b) study the conceptus dose as a function of chest thickness of the patient undergoing chest radiograph, and (c) investigate the possibility of a conceptus to receive a dose of more than 10 mGy, the level above which specific measurements of conceptus doses may be necessary. Thermoluminescent dosimeters were used for dose measurements in anthropomorphic phantoms simulating pregnancy at the three trimesters of gestation. The effect of chest thickness on conceptus dose and risk was studied by adding slabs of lucite on the anterior and posterior surface of the phantom chest. The conceptus risk for radiation-induced childhood fatal cancer and hereditary effects was calculated based on appropriate risk factors. The average AP chest dimension (d(a)) was estimated for 51 women of childbearing age from chest CT examinations. The value of d(a) was estimated to be 22.3 cm (17.4-27.2 cm). The calculated maximum conceptus dose was 107 x 10(-3) mGy for AP chest radiographs performed during the third trimester of pregnancy with maternal chest thickness of 27.2 cm. This calculation was based on dose data obtained from measurements in the phantoms and d(a) estimated from the patient group. The corresponding average excess of childhood cancer was 10.7 per million patients. The risk for hereditary effects was 1.1 per million births. Radiation dose for a conceptus increases exponentially as chest thickness increases. The conceptus dose at the third trimester is higher than that of the second and first trimesters. The results of the current study suggest that chest radiographs carried out in women at any time during gestation will result in a negligible increase in risk of radiation-induced harmful effects to the unborn child. After a properly performed maternal chest X-ray, there is no need for individual conceptus dose estimations.
Assuntos
Anormalidades Induzidas por Radiação/etiologia , Neoplasias Induzidas por Radiação/etiologia , Monitoramento de Radiação , Radiografia Torácica/efeitos adversos , Ecrans Intensificadores para Raios X/efeitos adversos , Anormalidades Induzidas por Radiação/prevenção & controle , Antropometria , Criança , Feminino , Idade Gestacional , Humanos , Recém-Nascido , Computação Matemática , Neoplasias Induzidas por Radiação/prevenção & controle , Imagens de Fantasmas , Doses de Radiação , Monitoramento de Radiação/estatística & dados numéricos , Medição de Risco , Dosimetria TermoluminescenteRESUMO
Certain assumptions have been made regarding the composition of the breast in different age groups: these are believed to be more realistic than existing assumptions and have been used in comprehensive Monte Carlo calculations of radiation dose to the breast and of appropriate indicators of risk as follows: (i) Mean dose to the sensitive tissues in an average breast. This may be used to compare risk in different mammographic techniques, and has been calculated for a wide variety of techniques, including some not previously explicitly studied. (ii) Integral dose to the sensitive tissues in a breast, which is a good indicator of risk in an individual case, has been calculated for two commonly used mammographic techniques and for four different breast compositions and thicknesses. The results have been compared with results obtained using other approaches.